Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase 2 Clinical Trial Agent (TBN) in Breast Dysplasia
Fabian, Carol J.
University of Kansas, Kansas City, KS, United States
Search 29 grants from Carol Fabian
Search grants from University of Kansas
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Cellular Epigenetic Heterogeneity as a Predeterminant of Malignant Transformation Potential
Investigating the Role of Long Gene Misregulation in Rett Syndrome
Cloning &Functional Studies of Deafness Mutations
Mechanisms of T Cell Tolerance
Activity vs Discourse to Improve Communication in Ad
Recently added grants:
Acute radiation injury alters microRNA profiles that predict late tissue-specific damage
Tapping into an anthelmintic Bacillus thuringiensis crystal protein arsenal for human strongyloidiasis
Rhinovirus C Infection in Normal and Asthmatic Human Airway Epithelium at Single Cell Resolution
Regulation of Neuromyelitis Optica via Tolerance Induced by PLG Nanoparticles Encapsulating Aquaporin 4 Epitopes
Assessing Flu-specific Humoral Immunity in Human Lung after Ex Vivo Lung Perfusion
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN065124-001
Application #
2849704
Study Section
Project Start
1996-09-26
Project End
1999-09-29
Budget Start
1998-07-28
Budget End
1999-09-29
Support Year
Fiscal Year
1998
Total Cost
Indirect Cost
Institution
Name
University of Kansas
Department
Pharmacology
Type
Schools of Medicine
DUNS #
016060860
City
Kansas City
State
KS
Country
United States
Zip Code
66160
Related projects
NIH 1999
N01 CN
Phase 2 Clinical Trial Agent (TBN) in Breast Dysplasia
Fabian, Carol J. / University of Kansas
NIH 1998
N01 CN
Phase 2 Clinical Trial Agent (TBN) in Breast Dysplasia
Fabian, Carol J. / University of Kansas
NIH 1996
N01 CN
Phase 2 Clinical Trial Agent (TBN) in Breast Dysplasia
Fabian, Carol J. / University of Kansas
Publications
Fabian, Carol J; Kimler, Bruce F; Brady, Deborah A et al.
(2002)
A phase II breast cancer chemoprevention trial of oral alpha-difluoromethylornithine: breast tissue, imaging, and serum and urine biomarkers.
Clin Cancer Res 8:3105-17
Comments
Be the first to comment on Carol Fabian's grant